Jingtian & Gongcheng Advises Qyuns Therapeutics on Its IPO in Hong Kong
Date：2024-03-20
Share：
Jiang Su Qyuns Therapeutics (Stock Code: 02509.HK) completed its IPO on the Main Board of the Hong Kong Stock Exchange on March 20, 2024.
As the Chinese legal advisor to the sponsor and the underwriter, Jingtian & Gongcheng took part in and provided full-process Chinese legal services for the IPO.
